当保险公司可以说“不”时会发生什么?评估预先授权作为预防高风险处方和降低成本的工具

What happens when the insurer can say no? Assessing prior authorization as a tool to prevent high-risk prescriptions and to lower costs

Journal of Public Economics · 2018
被引 23
人大 AABS 3
健康经济学医疗保险药品政策风险管理